Closed Formularies In Medicaid: Biden Orders Review Of Trump-Era Demonstrations, Waivers
Tennessee Medicaid demonstration approved by the Trump Administration and involving capped federal spending will likely be in the cross hairs of the federal agency review and possible withdrawal ordered by President Biden. But it's unclear whether the new Administration will also object to the demonstration's closed formulary.
You may also be interested in...
Chiquita Brooks-LaSure’s nomination was approved in a 55-44 vote, with five Republicans joining Democrats in favor. Her confirmation clears the way for other appointments to key positions at the agency, such as the directors of the centers for Medicare and Medicaid.
As MACPAC moves toward formal recommendations, a CBO analysis finds that differential Medicaid rebates for drugs approved through the accelerated pathway could save the federal government up to $1bn over five years.
Demonstration, which may not survive scrutiny from the Biden Administration, includes some protections, such as prohibiting Tennessee from excluding drugs described in the Medicare Part D protected classes policy.